2024 Sanofi Innovation Awards (iAwards)
Sanofi iAwards initiative is a multi-institutional partnership program designed to support collaborations with academic investigators to accelerate innovative early stage, disease-relevant research towards the clinic. With this program, Sanofi aims to fund cutting-edge translational research that can contribute to their early-stage pipeline and ultimately benefit patients. Please find a PDF of the Call for Pre-Proposals and the 2023-2024 Cycle Innovation Awards Pre-Proposal Submission Word Template attached. There should be NO confidential information disclosed in the pre-proposals.
Areas of Interest:
- Immunology & Inflammation
- Rare & Neurological Diseases
- Gene Therapy
- Oncology – Adult and childhood cancers
- Precision Medicine and Computational Biology
- See Call for Pre-proposals for details and additional information
Timeline:
- May 26, 2023 – Internal Submission Deadline to Stanford Medicine – Industry Relations team (nrmalek@stanford.edu)
- June 2, 2023 – Submission of completed Pre-Proposals to Sanofi by SM-IR
- July 11, 2023 – Notification Pre-Proposals chosen to be pursued; call for Full Proposals
- September 1, 2023 – Submission of Full Proposals to Sanofi by SM-IR
- October 12, 2023 – Feedback from Therapeutic Areas received, informational meetings scheduled
- October 24, 2023 – Announcements made for 2024 iAward winners
Stanford faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver). CE applicants must obtain an approved CE faculty PI waiver through their Research Process Manager (RPM) before the internal deadline on May 26, 2023.
Fill out the attached pre-proposal. Email complete pre-proposal to Nour Malek at nrmalek@stanford.edu. The Industry Relations team will review the submissions with the Industry Contracting Office (ICO) and then formally submit all pre-proposals through the Sanofi portal on behalf of Stanford.
There should be NO confidential information disclosed in the pre-proposals.
Institutional representative: you do not need to submit your pre-proposals through RMG or OSR for institutional approval; you may submit your pre-proposal directly to the program per the instructions above. If invited to submit a full proposal, please initiate your Proposal Intake Form (PIF) at your earliest convenience. Final proposal submission will require institutional approval prior to submission.
The funds can be used for FTE, supplies, equipment, data, services, etc. Along with funding, Sanofi R&D expertise and guidance will also be provided.
